Metacrine Initiates Phase 2a Combination Trial Of MET409 With Empagliflozin In Patients With Type 2 Diabetes And NASH

Press/Media: Press / Media

PeriodJan 5 2021 → Jan 6 2021

Media coverage

16

Media coverage

  • TitleMetacrine Initiates Phase 2a Combination Trial of MET409 with Empagliflozin in Patients with Type 2 Diabetes and NASH
    Media name/outletBioSpace
    CountryUnited States
    Date1/6/21
    PersonsEric J Lawitz
  • TitleMetacrine Initiates Phase 2a Combination Trial Of MET409 With Empagliflozin In Patients With Type 2 Diabetes And NASH
    Media name/outletTheStreet.com
    CountryUnited States
    Date1/5/21
    PersonsEric J Lawitz
  • TitleMetacrine Initiates Phase 2a Combination Trial of MET409 with Empagliflozin in Patients with Type 2 Diabetes and NASH
    Media name/outletMorningstar.com
    CountryUnited States
    Date1/5/21
    PersonsEric J Lawitz
  • Title$MTCR Metacrine Initiates Phase 2a Combination Trial of MET409 with Empagliflozin in Patients with Type 2 Diabetes and NASH
    Media name/outletOTC Dynamics
    CountryCanada
    Date1/5/21
    PersonsEric J Lawitz
  • TitleMetacrine Initiates Phase 2a Combination Trial of MET409 with Empagliflozin in Patients with Type 2 Diabetes and NASH
    Media name/outletYahoo! Finance
    CountryUnited States
    Date1/5/21
    PersonsEric J Lawitz
  • TitleMetacrine Initiates Phase 2a Combination Trial of MET409 with Empagliflozin in Patients with Type 2 Diabetes and NASH
    Media name/outletStocksNewsFeed.com
    CountryUnited States
    Date1/5/21
    PersonsEric J Lawitz
  • TitleMetacrine Initiates Phase 2a Combination Trial of MET409 with Empagliflozin in Patients with Type 2 Diabetes and NASH
    Media name/outletStockwatch
    CountryCanada
    Date1/5/21
    PersonsEric J Lawitz
  • TitleMetacrine Initiates Phase 2a Combination Trial of MET409 with Empagliflozin in Patients with Type 2 Diabetes and NASH
    Media name/outletCrwe World
    CountryUnited States
    Date1/5/21
    PersonsEric J Lawitz
  • TitleMetacrine Initiates Phase 2a Combination Trial of MET409 with Empagliflozin in Patients with Type 2 Diabetes and NASH
    Media name/outletSpoke.com
    CountryUnited States
    Date1/5/21
    PersonsEric J Lawitz
  • TitleMetacrine Initiates Phase 2a Combination Trial of MET409 with Empagliflozin in Patients with Type 2 Diabetes and NASH
    Media name/outletGlobeNewswire
    CountryUnited States
    Date1/5/21
    PersonsEric J Lawitz
  • TitleMetacrine Initiates Phase 2a Combination Trial of MET409 with Empagliflozin in Patients with Type 2 Diabetes and NASH
    Media name/outletNewbridge Securities Corporation
    CountryUnited States
    Date1/5/21
    PersonsEric J Lawitz
  • TitleMetacrine Initiates Phase 2a Combination Trial of MET409 with Empagliflozin in Patients with Type 2 Diabetes and NASH
    Media name/outletBizWire Express
    CountryIndia
    Date1/5/21
    PersonsEric J Lawitz
  • TitleMetacrine Initiates Phase 2a Combination Trial of MET409 with Empagliflozin in Patients with Type 2 Diabetes and NASH; Trial Designed to Evaluate Potential of FXR-Based Combination Therapy in a Growing Segment of NASH Patient Population with Significant U
    Media name/outletPrimeNewswire (Top News)
    CountryUnited States
    Date1/5/21
    PersonsEric J Lawitz
  • TitleInitiates Phase 2a Combination Trial of MET409 with Empagliflozin in Patients with Type 2 Diabetes and NASH
    Media name/outletMarket News Publishing
    CountryUnited States
    Date1/5/21
    PersonsEric J Lawitz
  • TitleMetacrine Initiates Phase 2a Combination Trial of MET409 with Empagliflozin in Patients with Type 2 Diabetes and NASH
    Media name/outletIndia Pharma News
    CountryIndia
    Date1/5/21
    PersonsEric J Lawitz
  • TitleMetacrine Initiates Phase 2a Combination Trial of MET409 with Empagliflozin in Patients with Type 2 Diabetes and NASH
    Media name/outletImpact Financial News
    CountryUnited Kingdom
    Date1/5/21
    PersonsEric J Lawitz